News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
866,785 Results
Type
Article (87741)
Company Profile (824)
Press Release (778201)
Multimedia
Podcasts (186)
Webinars (28)
Section
Business (233166)
Career Advice (4143)
Deals (39830)
Drug Delivery (144)
Drug Development (91352)
Employer Resources (203)
FDA (18351)
Job Trends (17414)
News (397692)
Policy (39947)
Tag
Academia (3006)
Academic (2)
Accelerated approval (25)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (170)
Alzheimer's disease (1755)
Antibody-drug conjugate (ADC) (302)
Approvals (18447)
Artificial intelligence (577)
Autoimmune disease (130)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (187)
Biotechnology (488)
Bladder cancer (149)
Brain cancer (61)
Breast cancer (609)
Cancer (4650)
Cardiovascular disease (406)
Career advice (3565)
Career pathing (40)
CAR-T (289)
CDC (59)
Celiac Disease (1)
Cell therapy (783)
Cervical cancer (36)
Clinical research (76495)
Collaboration (1584)
Company closure (5)
Compensation (1057)
Complete response letters (65)
COVID-19 (2976)
CRISPR (93)
C-suite (734)
Cystic fibrosis (147)
Data (5782)
Decentralized trials (2)
Denatured (68)
Depression (131)
Diabetes (492)
Diagnostics (7164)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (270)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (222)
Earnings (99879)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134488)
Executive appointments (1009)
FDA (21179)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1429)
Gene editing (201)
Generative AI (60)
Gene therapy (620)
GLP-1 (1082)
Government (5418)
Grass and pollen (8)
Guidances (379)
Healthcare (20941)
HIV (54)
Huntington's disease (44)
IgA nephropathy (80)
Immunology and inflammation (273)
Immuno-oncology (39)
Indications (76)
Infectious disease (3245)
Inflammatory bowel disease (197)
Inflation Reduction Act (16)
Influenza (111)
Intellectual property (217)
Interviews (816)
IPO (17942)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (652)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (646)
Lymphoma (358)
Machine learning (40)
Management (66)
Manufacturing (740)
MASH (164)
Medical device (14966)
Medtech (15005)
Mergers & acquisitions (22866)
Metabolic disorders (1283)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (321)
Neuropsychiatric disorders (85)
Neuroscience (2946)
NextGen: Class of 2025 (7703)
Non-profit (5102)
Now hiring (61)
Obesity (615)
Opinion (326)
Ovarian cancer (153)
Pain (185)
Pancreatic cancer (198)
Parkinson's disease (272)
Partnered (34)
Patents (468)
Patient recruitment (398)
Peanut (58)
People (66618)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23622)
Phase II (33205)
Phase III (25025)
Pipeline (3804)
Policy (318)
Postmarket research (3554)
Preclinical (10662)
Press Release (72)
Prostate cancer (226)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (797)
Real estate (7436)
Recruiting (80)
Regulatory (28517)
Reports (65)
Research institute (2715)
Resumes & cover letters (651)
Rett syndrome (23)
RNA editing (16)
RSV (82)
Schizophrenia (147)
Series A (234)
Series B (177)
Service/supplier (30)
Sickle cell disease (99)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (46)
Startups (4324)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (97)
The Weekly (116)
Vaccines (1102)
Venture capital (76)
Weight loss (432)
Women's health (77)
Worklife (21)
Date
Today (111)
Last 7 days (686)
Last 30 days (2861)
Last 365 days (33335)
2025 (32321)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (86)
Alaska (7)
Arizona (325)
Arkansas (14)
Asia (51300)
Australia (9014)
California (10771)
Canada (3157)
China (1044)
Colorado (453)
Connecticut (479)
Delaware (321)
Europe (117939)
Florida (1577)
Georgia (348)
Hawaii (3)
Idaho (68)
Illinois (888)
India (62)
Indiana (518)
Iowa (22)
Japan (374)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1394)
Massachusetts (7981)
Michigan (340)
Minnesota (625)
Mississippi (6)
Missouri (132)
Montana (34)
Nebraska (27)
Nevada (117)
New Hampshire (81)
New Jersey (2942)
New Mexico (32)
New York (2882)
North Carolina (1530)
North Dakota (10)
Northern California (5072)
Ohio (327)
Oklahoma (22)
Oregon (52)
Pennsylvania (2182)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4135)
Tennessee (166)
Texas (1693)
United States (39193)
Utah (323)
Vermont (1)
Virginia (270)
Washington D.C. (85)
Washington State (910)
West Virginia (4)
Wisconsin (112)
Wyoming (2)
There are 866,785 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Clinical research
‘Au Revoir TIGIT’: Gilead, Arcus Cut Gastro Cancer Drug After Late-Stage Failure
The loss of domvanalimab is the latest in a string of high-profile failures recorded across the biopharma world for the TIGIT modality, including from GSK, Merck and Roche.
December 12, 2025
·
3 min read
·
Annalee Armstrong
Vaccines
FDA Plans Black Box Warning for COVID-19 Vaccines: Report
The FDA intends to place a black box label—its most serious warning—on COVID-19 vaccines, according to reporting by
CNN
. It is unclear if the warning would apply to Moderna’s, Pfizer/BioNTech’s and Novavax’s shots, or to all age groups.
December 12, 2025
·
3 min read
·
Heather McKenzie
Press Releases
Marengo to Present Initial Results from Invikafusp Alfa and TRODELVY® Combination Study, STARt-002, at the 2025 San Antonio Breast Cancer Symposium
December 12, 2025
·
5 min read
Press Releases
Novartis breaks ground on flagship manufacturing hub in North Carolina
December 12, 2025
·
7 min read
Press Releases
BioCryst Announces FDA Approval of ORLADEYO® (berotralstat) Oral Pellets, First and Only Oral Prophylactic Treatment for Patients with HAE Aged 2 to <12 Years
December 12, 2025
·
9 min read
Press Releases
Revuforj® (revumenib) Named Best New Drug at the Scrip Awards 2025
December 12, 2025
·
11 min read
Press Releases
Relay Therapeutics Announces Efficacy Subset Analysis of Zovegalisib (RLY-2608) + Fulvestrant in Breast Cancer Patients Pre-Treated with SERD or with ESR1 Mutations at SABCS 2025
December 12, 2025
·
8 min read
Press Releases
Systematic Review and Meta-Analysis Confirms TissueCypher® Outperforms Traditional Pathology or Clinical Factors Alone to Identify Patients at Increased Risk of Developing Esophageal Cancer
December 12, 2025
·
6 min read
Press Releases
Option Care Health to Participate in the J.P. Morgan Healthcare Conference
December 12, 2025
·
1 min read
Press Releases
BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path
December 12, 2025
·
3 min read
1 of 86,679
Next
